
Urticaria
Latest News
Latest Videos

CME Content
More News

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.

A new phase 2b trial shows the investigative therapy significantly improves the rate of patients with hives control over 12 weeks versus its competitor.










In a real-world setting, omalizumab improved UAS scores, DLQI scores, response scores, and saw a similar or better safety profile.

Researchers compiled best practices for clinicians diagnosing and treating aquagenic urticaria (AU), a rare, but debilitating form of the skin disorder that leaves patients unable to bathe, sweat, or cry without breaking out in painful wheals.

A new study reported no increased incidence of heart disease in patients treated for chronic urticaria, despite prior research highlighting a potential association with other cardiac risk precursors.

Researchers highlight a new set of tests that could streamline the process involved in identifying autoimmune chronic urticaria.




















































